Cargando…
Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay
Cardiotoxicity has emerged as a major side effect of doxorubicin (DOX) treatment, affecting nearly 30% of patients within 5 years after chemotherapy. Heart failure is the first non-cancer cause of death in DOX-treated patients. Although many different molecular mechanisms explaining the cardiac dera...
Autores principales: | Schirone, Leonardo, D’Ambrosio, Luca, Forte, Maurizio, Genovese, Riccardo, Schiavon, Sonia, Spinosa, Giulia, Iacovone, Giuliano, Valenti, Valentina, Frati, Giacomo, Sciarretta, Sebastiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266202/ https://www.ncbi.nlm.nih.gov/pubmed/35805084 http://dx.doi.org/10.3390/cells11132000 |
Ejemplares similares
-
An Overview of the Molecular Mechanisms Associated with Myocardial Ischemic Injury: State of the Art and Translational Perspectives
por: Schirone, Leonardo, et al.
Publicado: (2022) -
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
por: Schirone, Leonardo, et al.
Publicado: (2023) -
New Insights Into the Role of GSK-3 in the Regulation of Human Cardiac Electrophysiology
por: Forte, Maurizio, et al.
Publicado: (2022) -
Aging-Related Decline of Autophagy in Patients with Atrial Fibrillation—A Post Hoc Analysis of the ATHERO-AF Study
por: Versaci, Francesco, et al.
Publicado: (2022) -
The impact of autophagy modulation on phenotype and survival of cardiac stromal cells under metabolic stress
por: Chimenti, Isotta, et al.
Publicado: (2022)